IL217861A0 - Porphyromonas gingivalis polypeptides - Google Patents

Porphyromonas gingivalis polypeptides

Info

Publication number
IL217861A0
IL217861A0 IL217861A IL21786112A IL217861A0 IL 217861 A0 IL217861 A0 IL 217861A0 IL 217861 A IL217861 A IL 217861A IL 21786112 A IL21786112 A IL 21786112A IL 217861 A0 IL217861 A0 IL 217861A0
Authority
IL
Israel
Prior art keywords
porphyromonas gingivalis
gingivalis polypeptides
polypeptides
porphyromonas
gingivalis
Prior art date
Application number
IL217861A
Other languages
English (en)
Original Assignee
Sanofi Pasteur Ltd
Yethon Jeremy
Mccluskey Jacqueline
Charlebois Robert
Quemenuer Laurence
Leach Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd, Yethon Jeremy, Mccluskey Jacqueline, Charlebois Robert, Quemenuer Laurence, Leach Michael filed Critical Sanofi Pasteur Ltd
Publication of IL217861A0 publication Critical patent/IL217861A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1257—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Bacteridaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL217861A 2009-08-02 2012-01-31 Porphyromonas gingivalis polypeptides IL217861A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23071709P 2009-08-02 2009-08-02
PCT/CA2010/001177 WO2011014947A1 (en) 2009-08-02 2010-07-30 Porphyromonas gingivalis polypeptides

Publications (1)

Publication Number Publication Date
IL217861A0 true IL217861A0 (en) 2012-03-29

Family

ID=43543841

Family Applications (1)

Application Number Title Priority Date Filing Date
IL217861A IL217861A0 (en) 2009-08-02 2012-01-31 Porphyromonas gingivalis polypeptides

Country Status (14)

Country Link
US (1) US9366673B2 (cg-RX-API-DMAC7.html)
EP (1) EP2462160A4 (cg-RX-API-DMAC7.html)
JP (2) JP5876411B2 (cg-RX-API-DMAC7.html)
KR (1) KR20120050469A (cg-RX-API-DMAC7.html)
CN (1) CN102712693A (cg-RX-API-DMAC7.html)
AR (1) AR085167A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010281313B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012002429A2 (cg-RX-API-DMAC7.html)
CA (1) CA2769231A1 (cg-RX-API-DMAC7.html)
IL (1) IL217861A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012001495A (cg-RX-API-DMAC7.html)
RU (1) RU2012107993A (cg-RX-API-DMAC7.html)
WO (1) WO2011014947A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201200799B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871213B2 (en) 2008-08-29 2014-10-28 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. gingivalis infection
MY162557A (en) * 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection
WO2014089706A1 (en) * 2012-12-14 2014-06-19 Sanofi Pasteur, Ltd. Methods for assessing immunogenicity
US20160347829A1 (en) * 2015-05-27 2016-12-01 Merial Inc. Compositions containing antimicrobial IgY antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (OHC) microorganisms
EA202090908A1 (ru) 2017-10-12 2020-10-29 Ваксайт, Инк. Вакцина и связанные композиции для лечения пародонтита и способ применения
US20230204594A1 (en) * 2021-11-17 2023-06-29 Nerd Bio Llc Systems and methods for real-time cellular drug-target engagement
CN114469863B (zh) * 2021-11-26 2023-09-26 南方医科大学南方医院 甾醇脂质体作为牙髓和牙本质药物传递系统的应用
CN116474096A (zh) * 2022-01-14 2023-07-25 中山大学附属口腔医院 靶向牙龈卟啉单胞菌RgpB在结直肠癌的治疗及预防中的应用
US20250289872A1 (en) * 2022-04-26 2025-09-18 K-Bio Investment, Llc Formulation for antigen-binding molecules that bind to porphyromonas gingivalis
CN120359045A (zh) * 2022-09-16 2025-07-22 英国Qjm生物信息有限公司 针对牙龈卟啉单胞菌的抗体和使用方法
TW202517779A (zh) 2023-07-19 2025-05-01 法商賽諾菲公司 牙齦卟啉單胞菌抗原性構築體
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用
CN119424610A (zh) * 2024-12-05 2025-02-14 重庆师范大学 具备抗衰老活性的重组蛋白制剂及其制备方法、应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888124A4 (en) * 1996-03-22 2001-04-11 Univ Georgia Res Found Immunogenic assemblies of Porphyromonas Gingivalis peptides and their methods
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
NZ504811A (en) * 1997-12-10 2003-10-31 Csl Ltd Porphorymonas gingivalis polypeptides and nucleotides
JP2003192616A (ja) * 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
JP2003286191A (ja) * 2002-03-27 2003-10-07 Univ Nihon 歯周病用粘膜免疫ワクチン
WO2004083425A1 (ja) * 2003-03-17 2004-09-30 Kirin Beer Kabushiki Kaisha 歯周病治療剤
JP2005179301A (ja) * 2003-12-22 2005-07-07 Univ Nihon 歯周病用経皮免疫ワクチン
CA2652957A1 (en) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
EP2176413A4 (en) * 2007-07-12 2012-08-01 Oral Health Australia Pty Ltd IMMUNOLOGY TREATMENT FOR BIOFILMS

Also Published As

Publication number Publication date
WO2011014947A1 (en) 2011-02-10
CA2769231A1 (en) 2011-02-10
JP2015178533A (ja) 2015-10-08
KR20120050469A (ko) 2012-05-18
CN102712693A (zh) 2012-10-03
MX2012001495A (es) 2012-08-03
AR085167A1 (es) 2013-09-18
BR112012002429A2 (pt) 2016-11-08
JP2013501007A (ja) 2013-01-10
ZA201200799B (en) 2013-06-26
JP5876411B2 (ja) 2016-03-02
RU2012107993A (ru) 2013-09-10
EP2462160A1 (en) 2012-06-13
AU2010281313B2 (en) 2015-09-03
AU2010281313A1 (en) 2012-03-08
EP2462160A4 (en) 2013-04-24
US20120156211A1 (en) 2012-06-21
US9366673B2 (en) 2016-06-14

Similar Documents

Publication Publication Date Title
ZA201200799B (en) Porphyromonas gingivalis polypeptides
IL252044B (en) actriib variant polypeptides
GB2469209B (en) Antenna
PL2445651T3 (pl) Opakowanie izolacyjne
ZA201108956B (en) Encapsulated switchgear
GB2470115B (en) Spectrophotometer
GB0902394D0 (en) Electric machine- cooling
GB0902390D0 (en) Electric machine - flux
GB201002405D0 (en) Electric machine - modular
EP2380416A4 (en) CARRYING CASE
HUE036937T2 (hu) Neodímiummal katalizált polibutadién
GB0900917D0 (en) Mass spectrometer
GB2473839B (en) Mass spectrometer
GB0902314D0 (en) Antennas
GB2470054B (en) Magnetising assembly
EP2453524A4 (en) ANTENNA
GB201009844D0 (en) Self-aligning ion-optics components
GB0913699D0 (en) Scientific aerosol
GB2476727B (en) Antenna
GB2481743B (en) Antenna
GB0902991D0 (en) Insulating member
GB0908804D0 (en) Sushi making appararatus
AU4397P (en) Berkshire xTriticosecale
GB2468953B (en) Freeze-cast components
GB0908139D0 (en) Mechanical seal-securing